PDF) Design, synthesis, and preliminary biological evaluation of novel ethyl 1-(2 '-hydroxy-3 '-aroxypropyl)-3-aryl-1H-pyrazole-5-carboxylate
Targeting IRAK4 for Degradation with PROTACs | ACS Medicinal Chemistry Letters
Publications – Santos Lab
Bioorganic & Medicinal Chemistry Letters | Vol 16, Issue 6, Pages 1451-1758 (15 March 2006) | ScienceDirect.com by Elsevier
Bioorganic & Medicinal Chemistry Letters | Vol 26, Issue 15, Pages 3381-3830 (1 August 2016) | ScienceDirect.com by Elsevier
Corrigendum to “Novel purine-based fluoroaryl-1,2,3-triazoles as neuroprotecting agents: Synthesis, neuronal cell culture
Dima Sabbah, Ph.D. PEER REVIEWED SCIENTIFIC ARTICLES (11SUBMITTED/ ACCEPTED/ PUBLISHED PEER REVIEWED ARTICLES) 1. Sweidan K.,
Writing Your Next Medicinal Chemistry Article: Journal Bibliometrics and Guiding Principles for Industrial Authors | Journal of Medicinal Chemistry
Bioorganic & Medicinal Chemistry Letters | Vol 21, Issue 21, Pages 6207-6614 (1 November 2011) | ScienceDirect.com by Elsevier
Bioorganic
Bioorganic & Medicinal Chemistry Letters | Journal | ScienceDirect.com by Elsevier
Publications_2012
![PDF) Corrigendum to “Synthesis and carbonic anhydrase inhibitory properties of novel chalcone substituted benzenesulfonamides” [Bioorg. Med. Chem. Lett. 26 (2016) 5867–5870]](https://i1.rgstatic.net/publication/318331613_Corrigendum_to_Synthesis_and_carbonic_anhydrase_inhibitory_properties_of_novel_chalcone_substituted_benzenesulfonamides_Bioorg_Med_Chem_Lett_26_2016_5867-5870/links/5e28005b92851c3aadcfb95e/largepreview.png "PDF) Corrigendum to “Synthesis and carbonic anhydrase inhibitory properties of novel chalcone substituted benzenesulfonamides” [Bioorg. Med. Chem. Lett. 26 (2016) 5867–5870]")
PDF) Corrigendum to “Synthesis and carbonic anhydrase inhibitory properties of novel chalcone substituted benzenesulfonamides” [Bioorg. Med. Chem. Lett. 26 (2016) 5867–5870]
Ohkanda Research Lab | Chemical Biology, Shinshu University
Design, Synthesis, and Evaluation of Highly Potent FAK-Targeting PROTACs | ACS Medicinal Chemistry Letters
Development of Highly Potent and Selective Steroidal Inhibitors and Degraders of CDK8 | ACS Medicinal Chemistry Letters
Publications & Patents - The Trippier Lab
![PDF) Corrigendum to “Discovery and SAR of 2-amino-5-[(thiomethyl)aryl]thiazoles as potent and selective Itk inhibitors” [Bioorg. Med. Chem. Lett. 16 (2006) 2411–2415] | Tai-An Lin - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/52287160/mini_magick20190123-29662-11w8dly.png?1548247061 "PDF) Corrigendum to “Discovery and SAR of 2-amino-5-[(thiomethyl)aryl]thiazoles as potent and selective Itk inhibitors” [Bioorg. Med. Chem. Lett. 16 (2006) 2411–2415] | Tai-An Lin - Academia.edu")
PDF) Corrigendum to “Discovery and SAR of 2-amino-5-[(thiomethyl)aryl]thiazoles as potent and selective Itk inhibitors” [Bioorg. Med. Chem. Lett. 16 (2006) 2411–2415] | Tai-An Lin - Academia.edu
PROTAC Technology: Opportunities and Challenges | ACS Medicinal Chemistry Letters
Writing Your Next Medicinal Chemistry Article: Journal Bibliometrics and Guiding Principles for Industrial Authors | Journal of Medicinal Chemistry
Writing Your Next Medicinal Chemistry Article: Journal Bibliometrics and Guiding Principles for Industrial Authors
名古屋大学大学院創薬科学研究科 天然物化学分野
